Inactivated Vaccine

An inactivated vaccine is a type of vaccine that uses a whole virus or bacteria that has been killed or inactivated to stimulate an immune response in the body. In the case of coronavirus, this involves using a dead or inactivated COVID-19 virus to trigger an immune response and prepare the body for a potential infection. The process of creating an inactivated vaccine involves growing large quantities of the virus in a controlled laboratory setting. The virus is then treated with a chemical or physical agent that kills or inactivates the virus without damaging its surface proteins. This process ensures that the virus cannot replicate or cause illness, but still retains its antigenic properties. When the inactivated vaccine is injected into the body, the immune system recognizes the viral particles as foreign and begins to produce antibodies against them. These antibodies help to neutralize the virus if the individual is exposed to a live virus in the future. Inactivated vaccines have been used for decades and have proven to be safe and effective against a range of infectious diseases, including polio, hepatitis A, and influenza. However, one of the drawbacks of inactivated vaccine is that it may require multiple doses to stimulate a strong and lasting immune response. In the case of the COVID-19 pandemic, inactivated vaccine is being developed and tested as a potential solution to prevent the spread of the virus. While the efficacy of the inactivated vaccine against COVID-19 is still being studied, it has shown promising results and could be an important tool in the fight against the pandemic.

Related Articles

13 article(s) found

RETRACTED: Efficacy of BCG Vaccine and Role of Non Specific Sensitivity Due to Atypical Mycobacteria

Full-text HTML Download PDF Download XML

COVID-19 Vaccine Development: Insights, Prospects and Challenges

Full-text HTML Download PDF Download XML

Vaccine Hesitancy: A significant Challange

Full-text HTML Download PDF Download XML

Dynamics of Infections and Number of Vaccines Needed to Avoid Covid-19 in Europe

Full-text HTML Download PDF Download XML

Characterization of the Vaccine Abdala

Full-text HTML Download PDF Download XML

FDA Should Re-evaluate All mRNA Vaccines and Revoke Their Use Authorizations (The Short Version).

Full-text HTML Download PDF Download XML

Expression of Concern: Potential Risks and Unknown Effects of mRNA Vaccines on Population Health (6th Rev). Damages Are Being Materialized

Full-text HTML Download PDF Download XML

Anti-COVID19 Vaccine among Workers at the Local Health Authority of Rieti (Italy). Study on the Vaccine Efficacy and Seroprevalence Post-Vaccination

Full-text HTML Download PDF Download XML

Epidemio-Clinical Profile of Acute Diarrhea in Children From 0 To 5 Years and Prevalence of Rotavirus Before and After the Introduction of the Rotasiil Vaccine in the Democratic Republic of Congo.

Full-text HTML Download PDF Download XML

The Effects of Dairy Consumption on Vaccine Immune Response and Immunoglobulins: A Systematic Literature Review

Full-text HTML Download PDF Download XML

Predictors of COVID-19 Vaccine Hesitancy in North-Central Nigeria

Full-text HTML Download PDF Download XML

Predictors of COVID-19 Vaccine Uptake Among Healthcare Workers in Kiambu County, Kenya

Full-text HTML Download PDF Download XML

Retraction: Efficacy of BCG Vaccine and Role of Non Specific Sensitivity Due to Atypical Mycobacteria

Full-text HTML Download PDF Download XML